Your browser doesn't support javascript.
loading
Sclerosing angiomatoid nodular transformation (SANT) of the spleen can be safely diagnosed by a core percutaneous ultrasound-guided biopsy.
Gómez Rubio, Mariano; Monasterios Maestra, Pierina; Camacho Castañeda, Francisca Inmaculada; Castillo-López, Guillermo; Esteban, Francisco Javier; Phares, Lucía; Sevilla, Sergio.
Affiliation
  • Gómez Rubio M; Digestive Diseases, Hospital Universitario de Getafe. Universidad Europea de Madrid, España.
  • Monasterios Maestra P; Digestive Diseases, Hospital Universitario de Getafe. Universidad Europea de Madrid, España.
  • Camacho Castañeda FI; Pathology, Hospital Universitario de Getafe. Universidad Europea de Madrid, España.
  • Castillo-López G; Digestive Diseases, Hospital Universitario de Getafe, España.
  • Esteban FJ; Internal Medicine, Hospital Universitario de Getafe, España.
  • Phares L; Digestive Diseases, Hospital Universitario de Getafe, España.
  • Sevilla S; Digestive Diseases, Hospital Universitario de Getafe, España.
Rev Esp Enferm Dig ; 2024 Apr 09.
Article in En | MEDLINE | ID: mdl-38591625
ABSTRACT
Sclerosing angiomatoid nodular transformation (SANT) is a rare benign lesion of the spleen. SANT cannot be distinguished from other benign or malignant splenic tumors based on imaging findings. So, diagnosis relies on histopathologic examination. Although splenectomy is frequently considered as an option, core needle biopsy tissue analysis is safe and accurate to avoid surgery.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Rev Esp Enferm Dig Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Country of publication: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Rev Esp Enferm Dig Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Country of publication: Spain